New Eczema Treatments

Dr Clayton is recruiting patients aged between 18 and 45 yrs with severe eczema for a new biologic drug for atopic eczema. For more information please contact me through the online enquiry.

Rosacea Update

MIRVASO® (brimonidine) topical gel, 0.33%* is the first and only FDA-approved treatment developed and indicated for persistent facial redness of rosacea. Facial redness is a common symptom of rosacea, a skin condition that affects an estimated…

New website

This is my first post on this website its 1am and I am still working on updating my previous site to this new cleaner site, with the help of my nephew Gregory Clayton.